Doximity (NYSE:DOCS) Director Kira Scherer Wampler Sells 2,000 Shares of Stock

Doximity, Inc. (NYSE:DOCS) Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $24.95, for a total transaction of $49,900.00. Following the completion of the transaction, the director directly owned 19,839 shares of the company’s stock, valued at $494,983.05. This trade represents a 9.16% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Doximity Stock Performance

Doximity stock traded up $0.86 during mid-day trading on Thursday, reaching $25.60. 2,466,382 shares of the company were exchanged, compared to its average volume of 4,198,125. The firm has a market cap of $4.56 billion, a P/E ratio of 30.12, a PEG ratio of 19.35 and a beta of 1.29. The business has a fifty day moving average of $22.48 and a 200 day moving average of $23.07. Doximity, Inc. has a 12-month low of $17.15 and a 12-month high of $76.51.

Doximity (NYSE:DOCS) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.13. The business had revenue of $156.62 million for the quarter. Doximity had a return on equity of 18.06% and a net margin of 25.48%.The company’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.36 earnings per share. Sell-side analysts predict that Doximity, Inc. will post 0.74 EPS for the current year.

Institutional Investors Weigh In On Doximity

A number of large investors have recently made changes to their positions in DOCS. Vanguard Group Inc. grew its holdings in shares of Doximity by 4.1% in the fourth quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company’s stock valued at $588,281,000 after purchasing an additional 518,916 shares during the period. Capital World Investors lifted its position in shares of Doximity by 5.1% during the fourth quarter. Capital World Investors now owns 5,654,875 shares of the company’s stock worth $250,398,000 after purchasing an additional 273,444 shares in the last quarter. Carmignac Gestion lifted its holdings in Doximity by 127.8% during the 1st quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock worth $100,480,000 after buying an additional 2,418,971 shares in the last quarter. Wellington Management Group LLP boosted its position in Doximity by 24.7% in the 2nd quarter. Wellington Management Group LLP now owns 3,135,113 shares of the company’s stock valued at $65,022,000 after buying an additional 621,464 shares during the period. Finally, Renaissance Technologies LLC boosted its position in Doximity by 29.4% in the 1st quarter. Renaissance Technologies LLC now owns 3,059,749 shares of the company’s stock valued at $71,292,000 after buying an additional 694,300 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Doximity in a research report on Wednesday, August 12th. Wells Fargo & Company lowered shares of Doximity from an “equal weight” rating to an “underweight” rating and set a $18.00 price target for the company. in a research report on Monday, August 10th. Barclays lifted their price objective on Doximity from $20.00 to $27.00 and gave the company an “equal weight” rating in a research note on Friday, August 21st. Jefferies Financial Group cut shares of Doximity from a “buy” rating to a “hold” rating and decreased their target price for the company from $51.00 to $19.00 in a research note on Thursday, May 14th. Finally, Wolfe Research upgraded Doximity to an “outperform” rating in a research report on Thursday, August 13th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $32.43.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.